| J0897 | Injection, denosumab, 1 mg | 36,660 | $20 | $659.9K |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 12,800 | $40 | $486.4K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 59,220 | $10 | $473.8K |
| J0517 | Injection, benralizumab, 1 mg | 1,020 | $130 | $135.7K |
| 99212 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,… | 1,070 | $50 | $53.6K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2,280 | $20 | $50.2K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 450 | $70 | $31.1K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 470 | $60 | $27.9K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 150 | $120 | $17.9K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 230 | $80 | $17.7K |